Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -10.47 |
peg ratio | 0.03 |
price to book ratio | 10.18 |
price to sales ratio | 5.50 |
enterprise value multiple | -13.01 |
price fair value | 10.18 |
profitability ratios | |
---|---|
gross profit margin | 91.92% |
operating profit margin | -46.33% |
pretax profit margin | -52.84% |
net profit margin | -52.53% |
return on assets | -45.86% |
return on equity | -93.32% |
return on capital employed | -55.43% |
liquidity ratio | |
---|---|
current ratio | 2.97 |
quick ratio | 2.60 |
cash ratio | 0.67 |
efficiency ratio | |
---|---|
days of inventory outstanding | 526.56 |
operating cycle | 624.58 |
days of payables outstanding | 258.98 |
cash conversion cycle | 365.60 |
receivables turnover | 3.72 |
payables turnover | 1.41 |
inventory turnover | 0.69 |
debt and solvency ratios | |
---|---|
debt ratio | 0.01 |
debt equity ratio | 0.03 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.03 |
interest coverage | -6.11 |
cash flow to debt ratio | -42.56 |
cash flow ratios | |
---|---|
free cash flow per share | -0.86 |
cash per share | 0.68 |
operating cash flow per share | -0.86 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -42.56 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -27,123,030.07 |
Frequently Asked Questions
Avadel Pharmaceuticals plc (AVDL) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Avadel Pharmaceuticals plc (NASDAQ:AVDL)'s trailing twelve months ROE is -93.32%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Avadel Pharmaceuticals plc (AVDL) currently has a ROA of -45.86%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
AVDL reported a profit margin of -52.53% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.97 in the most recent quarter. The quick ratio stood at 2.60, with a Debt/Eq ratio of 0.03.